SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-14-070506
Filing Date
2014-10-07
Accepted
2014-10-07 16:01:39
Documents
7
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a14-20586_310qa.htm 10-Q/A 43757
  Complete submission text file 0001104659-14-070506.txt   3453628

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT loxo-20140630.xml EX-101.INS 363871
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20140630.xsd EX-101.SCH 34253
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20140630_cal.xml EX-101.CAL 24274
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20140630_def.xml EX-101.DEF 250786
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20140630_lab.xml EX-101.LAB 566279
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20140630_pre.xml EX-101.PRE 317832
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36562 | Film No.: 141145681
SIC: 2834 Pharmaceutical Preparations